SkeikNNowariakMESmithJE, et al. Lipid-lowering therapies in peripheral artery disease: A review. Vasc Med2021; 26: 71–80.
2.
GornikHLAronowHDGoodneyPP, et al. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol2024; 83: 2497–2604.
3.
KonstantinidesSVMeyerGBecattiniC, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J2020; 41: 543–603.
4.
NilsenP.Making sense of implementation theories, models and frameworks. Implement Sci2015; 10: 53.
5.
KalbaughCAWitrickBHowardKA, et al. Investigating the impact of suboptimal prescription of preoperative antiplatelets and statins on race and ethnicity-related disparities in major limb amputation. Vasc Med2024; 29: 17–25.
6.
SecemskyEAKirkseyLQuirogaE, et al. Impact of intensity of vascular care preceding major amputation among patients with chronic limb-threatening ischemia. Circ Cardiovasc Interv2024; 17: e012798.
7.
NewmanJBrunoEAllenS, et al. The influence of patient sex on pulmonary embolism evaluation, treatment modality, and outcomes. Vasc Med2025; 30: 67–75.
8.
WatsonNWCarrollBJKrawiszA, et al. Trends in discharge rates for acute pulmonary embolism in U.S. emergency departments. Ann Intern Med2024; 177: 134–143.
9.
Al RowilyAJalalZPriceMJ, et al. Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: A systematic review and meta-analysis. Eur J Clin Pharmacol2022; 78: 623–645.
10.
NairKMizeBMWhiteMS, et al. Reporting of race, ethnicity, and gender in lower-extremity peripheral artery disease randomized controlled trials. Vasc Med2025; 30: 315–317.
11.
ReillyMAAlagnaMEIrozC, et al. Patient factors associated with activation level in peripheral artery disease. Vasc Med2025; 30: 283–292.
12.
AlabiOCarlYSanchetiM, et al. Disease-specific knowledge among veterans with peripheral artery disease. Vasc Med2025; 30: 309–311.
13.
ParsonsGRParvathinathanGEtemadiA, et al. Identifying peripheral artery disease in persons with and without chronic kidney disease from electronic health records. Vasc Med2025; 30: 312–314.
14.
SivaganganPMancusoESandersI, et al. Systematic review of tracking-based technology for patients with claudication. Vasc Med2025; 30: 353–363.
15.
CallegariSRomainGCapuanoI, et al. Association between guideline-directed medical therapy and reintervention risk following peripheral vascular interventions in patients with peripheral artery disease. Vasc Med2025; 30: 293–301.
16.
HessCNDaffronANehlerMR, et al. Early combination lipid-lowering therapy is associated with greater achievement of goal LDL-C: Insights from the OPTIMIZE PAD-1 trial. Vasc Med2025; 30: 321–323.
